Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Biochem Pharmacol. 2010 Jun 23;80(7):1021–1032. doi: 10.1016/j.bcp.2010.06.022

Figure 3.

Figure 3

(A) Effect of CDC and curcumin on proliferation/survival as assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. CDC is more active than curcumin in suppressing proliferation at different days. (B) CDC showed more cytotoxic in different cancer cells. KBM-5 (human chronic myeloid leukemia), SCC-4 (human tongue squamous cancer), Caco-2 (human colonic carcinoma), and Panc-28 cells (pancreatic cancer) were incubated with different concentrations of either curcumin or CDC in for 72 h and then examined for cell viability by the MTT method. The results show the mean ± SD values.